Patents by Inventor Mark A. Seefeld

Mark A. Seefeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090275572
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Application
    Filed: March 12, 2009
    Publication date: November 5, 2009
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Walter E. Dewolf, JR., Dalia R. Jakas
  • Publication number: 20090221699
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    Type: Application
    Filed: June 25, 2007
    Publication date: September 3, 2009
    Inventors: Walter J. Burgess, Dalia Jakas, William F. Huffman, William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas
  • Publication number: 20090209607
    Abstract: Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
    Type: Application
    Filed: February 7, 2008
    Publication date: August 20, 2009
    Inventors: Mark A. Seefeld, Meagan B. Rouse, Dirk A. Heerding
  • Patent number: 7557125
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: December 9, 2004
    Date of Patent: July 7, 2009
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Walter E. DeWolf, Dalia R. Jakas
  • Patent number: 7524843
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Grant
    Filed: July 18, 2007
    Date of Patent: April 28, 2009
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Walter E. Dewolf, Jr., Dalia R. Jakas
  • Publication number: 20080234256
    Abstract: Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: January 24, 2006
    Publication date: September 25, 2008
    Applicant: Glaxo Group Limited
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Publication number: 20080125423
    Abstract: Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections.
    Type: Application
    Filed: July 18, 2007
    Publication date: May 29, 2008
    Inventors: William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas, Walter E. Dewolf, Dalia R. Jakas
  • Publication number: 20080009483
    Abstract: Napthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed.
    Type: Application
    Filed: January 24, 2006
    Publication date: January 10, 2008
    Applicant: Glaxo Group Limited
    Inventors: William Miller, Mark Seefeld
  • Publication number: 20070287701
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: June 15, 2005
    Publication date: December 13, 2007
    Inventors: William Miller, Israil Pendrak, Mark Seefeld
  • Publication number: 20070270417
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 21, 2005
    Publication date: November 22, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Publication number: 20070254872
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 8, 2005
    Publication date: November 1, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Publication number: 20070244091
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: August 2, 2005
    Publication date: October 18, 2007
    Inventors: William Miller, Mark Seefeld
  • Publication number: 20070203127
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 13, 2005
    Publication date: August 30, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Jeffrey Axten, Mark Seefeld
  • Patent number: 7250424
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: July 31, 2007
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Walter J. Burgess, Dalia R. Jakas, William F. Huffman, William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas
  • Publication number: 20070161627
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: August 9, 2005
    Publication date: July 12, 2007
    Inventors: William Miller, Meagan Rouse, Mark Seefeld
  • Publication number: 20070004710
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: November 4, 2003
    Publication date: January 4, 2007
    Inventors: Jeffrey Axten, Timothy Gallagher, William Miller, Mark Seefeld
  • Publication number: 20060189601
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: March 26, 2004
    Publication date: August 24, 2006
    Inventors: Alan Hennessy, William Miller, Mark Seefeld
  • Publication number: 20060116394
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    Type: Application
    Filed: November 22, 2005
    Publication date: June 1, 2006
    Inventors: Walter Burgess, Dalia Jakas, William Huffman, William Miller, Kenneth Newlander, Mark Seefeld, Irene Uzinskas
  • Patent number: 7048926
    Abstract: The invention provides methods for using agonists and antagonists of FabK polypeptides, particularly to modulate the metabolism of bacteria or to treat bacterial infection.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: May 23, 2006
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Martin Brandt, Walter E. DeWolf, Jr., Paul M. Keller, Arunbhai H. Patel, David J. Payne, Shannon L. Reed, Mark A. Seefeld, David G. Tew, Nicola G. Wallis, Joshua M. West
  • Patent number: 7049310
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: May 23, 2006
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Walter J. Burgess, Dalia Jakas, William F. Huffman, William H. Miller, Kenneth A. Newlander, Mark A. Seefeld, Irene N. Uzinskas